PROTALIX BIOTHERAPEUTICS, INC. (PLX) Shareholders’ equity 2016–2025
PROTALIX BIOTHERAPEUTICS, INC. (PLX) shareholders’ equity at each fiscal year-end, per SEC filings.
$48.2MFY2025 · since FY2016: -$10.0M → $48.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.2M | +11.6% |
| FY2024 | $43.2M | +28.7% |
| FY2023 | $33.6M | +415.5% |
| FY2022 | -$10.6M | -76.3% |
| FY2021 | -$6.0M | +77.7% |
| FY2020 | -$27.0M | +61.6% |
| FY2019 | -$70.3M | -33.0% |
| FY2018 | -$52.9M | -79.5% |
| FY2017 | -$29.5M | -195.8% |
| FY2016 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice